Lets talk about Excellagen
Facts
1. A company tried this product before, look here:
https://www.cardiumthx.com/
2. Started in 2011 after a lot of PR
https://www.news-medical.net/news/20111011/FD...lcers.aspx
3. Gave up I guess after 2017
https://www.marketwatch.com/press-release/exc...2017-06-13
4. Comes back around
http://ir.collagensolutions.com/content/news/2019/150119.asp
(Read that second paragraph closely)
5. here is the interesting thing
https://www.allpennystocks.com/specialreports...40-million
One more thing
6
https://www.excellagen.com/about
read the last line
"Excellagen should not be used in individuals with a known sensitivity to bovine collagen."
So google it
https://www.google.com/search?client=firefox-...V3VfUyHg5g
So many products already exist with this in it, what makes it unique? Why such an insane price they think they can get it? Some quick lookups show these products today bill at 25% of what this company thinks they can get
That's right, this "newly found" company wants to make this. Keep in mind as you read the above, it is my thought, they have sold ZERO so far, and maybe I am wrong, but cannot find anything about sales. 8 years later
So in Sept 2018, they pay $4 mill for this thing. What does Generex do?
Pays 12 million for a little over half the company a few months later?
So a "new" company basically buys a license for the USA.
How could this make sense?
Just asking questions, more to follow.
Invest carefully
PS, I asked this company about the billing code for the product. It is a product to be used at a hospital, doctors office, etc, is not something you get at a pharmacy.
As of this date, they have not given me the code or shown proof of a reimbursement.
They said they "think" the code may be CPT-17999, which makes no sense to me.
PPS, i am in the space of assisting medical professionals find good quality care products for patients, that make sense This is why this is bothering me so much, along with more as you will see
Facts
1. A company tried this product before, look here:
https://www.cardiumthx.com/
2. Started in 2011 after a lot of PR
https://www.news-medical.net/news/20111011/FD...lcers.aspx
3. Gave up I guess after 2017
https://www.marketwatch.com/press-release/exc...2017-06-13
4. Comes back around
http://ir.collagensolutions.com/content/news/2019/150119.asp
(Read that second paragraph closely)
5. here is the interesting thing
https://www.allpennystocks.com/specialreports...40-million
One more thing
6
https://www.excellagen.com/about
read the last line
"Excellagen should not be used in individuals with a known sensitivity to bovine collagen."
So google it
https://www.google.com/search?client=firefox-...V3VfUyHg5g
So many products already exist with this in it, what makes it unique? Why such an insane price they think they can get it? Some quick lookups show these products today bill at 25% of what this company thinks they can get
That's right, this "newly found" company wants to make this. Keep in mind as you read the above, it is my thought, they have sold ZERO so far, and maybe I am wrong, but cannot find anything about sales. 8 years later
So in Sept 2018, they pay $4 mill for this thing. What does Generex do?
Pays 12 million for a little over half the company a few months later?
So a "new" company basically buys a license for the USA.
How could this make sense?
Just asking questions, more to follow.
Invest carefully
PS, I asked this company about the billing code for the product. It is a product to be used at a hospital, doctors office, etc, is not something you get at a pharmacy.
As of this date, they have not given me the code or shown proof of a reimbursement.
They said they "think" the code may be CPT-17999, which makes no sense to me.
PPS, i am in the space of assisting medical professionals find good quality care products for patients, that make sense This is why this is bothering me so much, along with more as you will see
